Term
|
Definition
Nitroglycerin (Nitro-Bid®)
Amyl Nitrite
Isosorbide dinitrate (Isordil®)
MOA: Converted to NO which causes vasodilation to provide more blood flowing to through the arteries |
|
|
Term
|
Definition
Nitro-Bid®, Nitro-Dur®, Nitrolingual®, NitroMist®, Nitro-Quick®, Nitrostat®, NitroTime®, Minitran®
Nitrate/Nitrite |
|
|
Term
|
Definition
No Brand Name
Nitrate/Nitrite |
|
|
Term
|
Definition
|
|
Term
|
Definition
Propranolol (Inderal®)
Atenolol (Tenormin®)
Metoprolol (Lopressor®)
Nadolol (Corgard®)
Timolol (Blocadren®)
MOA: B1 effects cause a decrease in myocardial contractility resulting in a decrease in O2 demand |
|
|
Term
|
Definition
|
|
Term
|
Definition
|
|
Term
|
Definition
|
|
Term
|
Definition
|
|
Term
|
Definition
|
|
Term
Dihyropyridine Calcium Channel Blockers |
|
Definition
Nifedipine (Adalat®)
Nisoldipine (Sular®)
Isradine (Dynacirc®)
Felodipine (Plendil®)
Clevipidine (Cleviprex®)
Amlodipine (Norvasc®)
Nicardipine (Cardene®)
MOA: Cause vasodilation resulting in increased blood flow to arteries |
|
|
Term
|
Definition
Adalat®, Procardia®
Dihydropyridine CCB |
|
|
Term
|
Definition
Sular®
Dihydropyridine CCB |
|
|
Term
|
Definition
DynaCirc®
Dihydropyridine CCB |
|
|
Term
|
Definition
Plendil®
Dihydropyridine CCB |
|
|
Term
|
Definition
Cleviprex®
Dihydropyridine CCB |
|
|
Term
|
Definition
Norvasc®
Dihydropyridine CCB |
|
|
Term
|
Definition
Cardene®
Dihydropyridine CCB |
|
|
Term
Nondihydropyridine Calcium Channel Blockers |
|
Definition
Verapamil (Calan®)
Diltiazem (Cardizem®)
MOA: Decrease myocardial contractility to decrease O2 demand and also causes vasodilation |
|
|
Term
|
Definition
Calan®, Isoptin®
Nondihydropyridine CCB |
|
|
Term
|
Definition
Cardizem®
Nondihydropyridine CCB |
|
|
